Novel Treatment, Lumoxiti Injection, Approved for ' Hairy Cell ' Leukemia

THURSDAY, Sept. 13, 2018 -- Lumoxiti injection has been approved to treat certain instances of relapsed or refractory " hairy cell " leukemia (HCL), the U.S. Food and Drug Administration said Thursday. Lumoxiti (moxetumomab pasudotox-tdfk) is among a...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news